Therigy Competitors and Similar CompaniesClear all
Audientes's competitors and similar companies include PepGen.
 PepGen PepGen is a clinical-stage biotechnology company developing next-generation of oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases. | ||
Founding Date | Founding Date 2014 | Founding Date 2018 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations HQ | Locations Boston, US HQ |
Employees | Employees N/A | Employees 8127% increase |
Financial | ||
Net income | Net income (kr10.7m) (FY, 2024) | Net income ($89.7m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
PepGen
HQ
Boston, US
Employees
81↑ 27% increase
PepGen is a clinical-stage biotechnology company developing next-generation of oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases.
View company